Currencies / APGE
APGE: Apogee Therapeutics Inc
36.37
USD
0.25
(0.68%)
APGE exchange rate has changed by -0.68% for today. During the day, the instrument was traded at a low of 35.70 and at a high of 37.35.
Follow Apogee Therapeutics Inc dynamics. Real-time quotes will help you quickly react to market changes. By switching between different timeframes, you can monitor exchange rate trends and dynamics by minutes, hours, days, weeks, and months. Use this information to forecast market changes and to make informed trading decisions.
- M5
- M15
- M30
- H1
- H4
- D1
- W1
- MN
APGE News
- InvestingPro Fair Value model captures 43% downside in Apogee Therapeutics
- Wall Street Analysts See a 152.41% Upside in Apogee Therapeutics Inc. (APGE): Can the Stock Really Move This High?
- InvestingPro Fair Value model captures 43% downside in Apogee Therapeutics
- Stifel reiterates Buy rating on Apogee Therapeutics stock amid positive AD data
- Apogee Therapeutics: Funding Supports Best-In-Class Ambitions In Atopic Dermatitis (APGE)
- Gold Falls 1%; ProKidney Shares Spike Higher - Apogee Therapeutics (NASDAQ:APGE), Blue Gold (NASDAQ:BGL)
- Jefferies raises Apogee Therapeutics stock price target to $96 on promising trial data
- Canaccord Genuity reaffirms Buy rating on Apogee Therapeutics stock after positive trial data
- Apogee Therapeutics stock maintains Buy rating at Citi after positive data
- Dow Dips 1%; Mustang Bio Shares Spike Higher - Apogee Therapeutics (NASDAQ:APGE), Artelo Biosciences (NASDAQ:ARTL)
- Apogee Dives. But It Could Eventually Rival Sanofi's Biggest Moneymaker.
- Top 2 Health Care Stocks That May Plunge This Month - Apogee Therapeutics (NASDAQ:APGE), Phibro Animal Health (NASDAQ:PAHC)
- Why Is Apogee Therapeutics Stock Soaring On Monday? - Apogee Therapeutics (NASDAQ:APGE)
- Apogee stock soars after positive atopic dermatitis trial data
- Why Apogee Therapeutics Shares Are Trading Higher By 50%; Here Are 20 Stocks Moving Premarket - Apogee Therapeutics (NASDAQ:APGE), Apogee Enterprises (NASDAQ:APOG)
- Apogee’s atopic dermatitis drug shows strong efficacy in phase 2 trial
- Guggenheim reiterates Buy on Apogee Therapeutics stock ahead of key data
- Apogee Therapeutics stock maintains buy rating at Stifel ahead of data
- Apogee Therapeutics stock maintains buy rating ahead of key trial data
- Apogee Therapeutics to Participate at the Jefferies Global Healthcare Conference
- Stifel maintains Buy rating, $35 target on Apogee Therapeutics stock
- Canaccord maintains Buy on Apogee stock, $89 price target
- Why Is Apogee Therapeutics Stock Trading Higher On Monday? - Apogee Therapeutics (NASDAQ:APGE)
- Apogee Therapeutics: Engineering Biologic Dominance (NASDAQ:APGE)
Daily Range
35.70
37.35
Year Range
26.20
63.36
- Previous Close
- 36.62
- Open
- 36.65
- Bid
- 36.37
- Ask
- 36.67
- Low
- 35.70
- High
- 37.35
- Volume
- 1.014 K
- Daily Change
- -0.68%
- Month Change
- -3.27%
- 6 Months Change
- 11.43%
- Year Change
- -29.13%
31 August, Sunday